[1]
|
Furuta, S., Iwamoto, T. and Nakajima, H. (2019) Update on Eosinophilic Granulomatosis with Polyangiitis. Allergology International: Official Journal of the Japanese Society of Allergology, 68, 430-436.
https://doi.org/10.1016/j.alit.2019.06.004
|
[2]
|
Churg, J. and Strauss, L. (1951) Allergic Granulomatosis, Allergic Angiitis, and Periarteritis Nodosa. The American Journal of Pathology, 27, 277-301.
|
[3]
|
Jennette, J.C., Falk, R.J., Ba-con, P.A., Basu, N., Cid, M.C., Ferrario, F., Flores-Suarez, L.F., Gross, W.L., Guillevin, L., Hagen, E.C., Hoffman, G.S., Jayne, D.R., Kallenberg, C.G., Lamprecht, P., Langford, C.A., Luqmani, R.A., Mahr, A.D., Matteson, E.L., Mer-kel, P.A., Ozen, S. and Watts, R.A. (2013) 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis and Rheumatism, 65, 1-11. https://doi.org/10.1002/art.37715
|
[4]
|
Hao, Y.X., Lou, J.T. and Wei, F. (2016) A Case Report of Eosinophilic Granulomatous Polyvasculitis Misdiagnosed as Asthma. Modern Medicine and Hygiene, No. 14, 2272-2274.
|
[5]
|
Mouthon, L., Dunogue, B. and Guillevin, L. (2014) Diagnosis and Classification of Eosinophilic Granulomatosis with Polyangiitis (Formerly Named Churg-Strauss Syndrome). Journal of Autoimmunity, 48-49, 99-103.
https://doi.org/10.1016/j.jaut.2014.01.018
|
[6]
|
Masi, A.T., Hunder, G.G., Lie, J.T., Michel, B.A., Bloch, D.A., Arend, W.P., Calabrese, L.H., Edworthy, S.M., et al. (1990) The American College of Rheumatology 1990 Criteria for the Classification of Churg-Strauss Syndrome (Allergic Granulomatosis and Angiitis). Arthritis and Rheumatism, 33, 1094-1100.
https://doi.org/10.1002/art.1780330806
|
[7]
|
Cottin, V., Bel, E., Bottero, P., Dalhoff, K., Humbert, M., Lazor, R., Sinico, R.A., Sivasothy, P., Wechsler, M.E., Groh, M., Marchand-Adam, S., Khouatra, C., Wallaert, B., Taillé, C., Dela-val, P., Cadranel, J., Bonniaud, P., Prévot, G., Hirschi, S., Gondouin, A. and Groupe d’Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERM“O”P) (2017) Revisiting the Systemic Vasculitis in Eosinophilic Granulo-matosis with Polyangiitis (Churg-Strauss): A Study of 157 Patients by the Groupe d’Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss). Autoimmunity Reviews, 16, 1-9. https://doi.org/10.1016/j.autrev.2016.09.018
|
[8]
|
Khoury, P., Grayson, P.C. and Klion, A.D. (2014) Eosinophils in Vasculitis: Characteristics and Roles in Pathogenesis. Nature Reviews. Rheumatology, 10, 474-483. https://doi.org/10.1038/nrrheum.2014.98
|
[9]
|
Cornec, D., Cornec-Le Gall, E., Fervenza, F.C. and Specks, U. (2016) ANCA-Associated Vasculitis—Clinical Utility of Using ANCA Specificity to Classify Patients. Nature Reviews. Rheumatology, 12, 570-579.
https://doi.org/10.1038/nrrheum.2016.123
|
[10]
|
Gioffredi, A., Maritati, F., Oliva, E. and Buzio, C. (2014) Eosino-philic Granulomatosis with Polyangiitis: An Overview. Frontiers in Immunology, 5, Article No. 549. https://doi.org/10.3389/fimmu.2014.00549
|
[11]
|
Guillevin, L., Cohen, P., Gayraud, M., Lhote, F., Jarrousse, B. and Casassus, P. (1999) Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine, 78(1), 26-37.
https://doi.org/10.1097/00005792-199901000-00003
|
[12]
|
Ito, T., Fujita, S.I., Kanzaki, Y., Sohmiya, K. and Hosh-iga, M. (2018) Eosinophilic Granulomatosis with Polyangiitis (EGPA) with an Unusual Manifestation of Mid-Ventricular Obstruction Caused by Endocardial Thrombus. The American Journal of Case Reports, 19, 1197-1203. https://doi.org/10.12659/AJCR.910861
|
[13]
|
Guillevin, L., Lhote, F., Gayraud, M., Cohen, P., Jarrousse, B., Lortholary, O., Thibult, N. and Casassus, P. (1996) Prognostic Factors in Polyarteritis Nodosa and Churg-Strauss Syn-drome. A Prospective Study in 342 Patients. Medicine, 75, 17-28. https://doi.org/10.1097/00005792-199601000-00003
|
[14]
|
Wechsler, M.E., Akuthota, P., Jayne, D., Khoury, P., Klion, A., Langford, C.A., Merkel, P.A., Moosig, F., Specks, U., Cid, M.C., Luqmani, R., Brown, J., Mallett, S., Philipson, R., Yancey, S.W., Steinfeld, J., Weller, P.F., Gleich, G.J. and EGPA Mepolizumab Study Team (2017) Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis. The New England Journal of Medicine, 376, 1921-1932. https://doi.org/10.1056/NEJMoa1702079
|
[15]
|
Aguirre-Valencia, D., Posso-Osorio, I., Bravo, J.C., Bonilla-Abadía, F., Tobón, G.J. and Cañas, C.A. (2017) Sequential Rituximab and Omalizumab for the Treatment of Eo-sinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome). Clinical Rheumatology, 36, 2159-2162. https://doi.org/10.1007/s10067-017-3780-9
|
[16]
|
Celebi Sozener, Z., Gorgulu, B., Mungan, D., Sin, B.A., Misirligil, Z., Aydin, O. and Bavbek, S. (2018) Omalizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA): Single-Center Experience in 18 Cases. The World Allergy Organization Journal, 11, 39. https://doi.org/10.1186/s40413-018-0217-0
|
[17]
|
Mohammad, A.J., Jacobsson, L.T., Mahr, A.D., Sturfelt, G. and Segelmark, M. (2007) Prevalence of Wegener’s Granulomatosis, Microscopic Polyangiitis, Polyarteritis Nodosa and Churg-Strauss Syndrome within a Defined Population in Southern Sweden. Rheumatology (Oxford, England), 46, 1329-1337. https://doi.org/10.1093/rheumatology/kem107
|